Literature DB >> 16149138

Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women.

Hyeon-Chang Kim1, Sung-Hee Choi, Hae-Won Shin, Jae-Youn Cheong, Kwan-Woo Lee, Hyun-Chul Lee, Kap-Bum Huh, Dae-Jung Kim.   

Abstract

AIM: To evaluate the association between the severity of liver steatosis and metabolic syndrome in apparently healthy Korean adults.
METHODS: We examined 1 022 men and women, aged 30-79 years, who participated in a health screening test. A standard interview, anthropometrics, biochemical studies, and abdominal ultrasonography were conducted for each participant. Metabolic syndrome was defined according to the National Cholesterol Education Program Adult Treatment Panel III, with a modification for the waist circumference cut-off level. The severity of liver steatosis was evaluated using liver ultrasonography, and serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (gamma-GT) levels were determined.
RESULTS: Ultrasonographic liver steatosis was strongly associated with metabolic syndrome and common metabolic abnormalities. Compared with people without steatosis, people with mild, moderate, and severe steatosis had adjusted odds ratios for metabolic syndrome of 1.72 (95%CI, 1.01-2.94), 2.89 (1.75-4.76) and 3.53 (1.25-9.98) in men, and 2.86 (1.64-5.01), 3.19 (1.80-5.65) and 3.70 (0.82-16.73) in women, respectively. The serum AST level was not associated with metabolic syndrome. The serum ALT and gamma-GT levels were significantly associated with metabolic syndrome in men but not in women.
CONCLUSION: The occurrence of metabolic syndrome shows a stronger association with the severity of ultrasonographic steatosis than with the serum liver enzyme levels. The degree of fatty infiltration detected on ultrasonography can be used as an indicator of liver dysfunction attributable to metabolic abnormalities.

Entities:  

Mesh:

Year:  2005        PMID: 16149138      PMCID: PMC4622801          DOI: 10.3748/wjg.v11.i34.5314

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  42 in total

1.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

Authors:  J B Dixon; P S Bhathal; P E O'Brien
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

2.  Surgical removal of visceral fat reverses hepatic insulin resistance.

Authors:  N Barzilai; L She; B Q Liu; P Vuguin; P Cohen; J Wang; L Rossetti
Journal:  Diabetes       Date:  1999-01       Impact factor: 9.461

Review 3.  The metabolic abnormalities associated with non-alcoholic fatty liver disease.

Authors:  Mahmadul Haque; Arun J Sanyal
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-10       Impact factor: 3.043

4.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

5.  Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects.

Authors:  C Loguercio; V De Girolamo; I de Sio; C Tuccillo; A Ascione; F Baldi; G Budillon; L Cimino; A Di Carlo; M P Di Marino; F Morisco; F Picciotto; L Terracciano; R Vecchione; V Verde; C Del Vecchio Blanco
Journal:  J Hepatol       Date:  2001-11       Impact factor: 25.083

Review 6.  Etiopathogenesis of nonalcoholic steatohepatitis.

Authors:  S Chitturi; G C Farrell
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

7.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

8.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

Review 9.  Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

Authors:  Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2003-02       Impact factor: 4.029

10.  The prevalence and etiology of elevated aminotransferase levels in the United States.

Authors:  Jeanne M Clark; Frederick L Brancati; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

View more
  13 in total

Review 1.  From bed to bench: which attitude towards the laboratory liver tests should health care practitioners strike?

Authors:  Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

2.  Serum γ-Glutamyltransferase, Alanine Aminotransferase and Aspartate Aminotransferase Activity in Healthy Blood Donor of Different Ethnic Groups in Gorgan.

Authors:  Abdoljalal Marjani; Masoumeh Mehrpouya; Zeinab Pourhashem
Journal:  J Clin Diagn Res       Date:  2016-07-01

3.  Serum gamma-glutamyltransferase, alanine aminotransferase, and aspartate aminotransferase activity in Iranian healthy blood donor men.

Authors:  Hossein Khedmat; Farahnaz Fallahian; Hassan Abolghasemi; Bashir Hajibeigi; Zohre Attarchi; Farshid Alaeddini; Mohammad Taghi Holisaz; Masoumeh Pourali; Shahin Sharifi; Nasrin Zarei
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

4.  Fatty liver, carotid disease and gallstones: a study of age-related associations.

Authors:  Amedeo Lonardo; Silvia Lombardini; Federica Scaglioni; Stefano Ballestri; Anna-Maria Verrone; Marco Bertolotti; Lucia Carulli; Dorval Ganazzi; Nicola Carulli; Paola Loria
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

Review 5.  Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.

Authors:  Nancy Khov; Amol Sharma; Thomas R Riley
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

Review 6.  Exercise in the metabolic syndrome.

Authors:  Saeid Golbidi; Azam Mesdaghinia; Ismail Laher
Journal:  Oxid Med Cell Longev       Date:  2012-07-05       Impact factor: 6.543

7.  Comparison of serum ferritin and vitamin d in association with the severity of nonalcoholic Fatty liver disease in korean adults.

Authors:  Dong Wook Jeong; Hye Won Lee; Young Hye Cho; Dong Won Yi; Sang Yeoup Lee; Seok Man Son; Yang Ho Kang
Journal:  Endocrinol Metab (Seoul)       Date:  2014-12-29

8.  Metabolic Syndrome and Serum Liver Enzymes in the General Chinese Population.

Authors:  Shuang Chen; Xiaofan Guo; Shasha Yu; Ying Zhou; Zhao Li; Yingxian Sun
Journal:  Int J Environ Res Public Health       Date:  2016-02-17       Impact factor: 3.390

9.  Fatty liver in children.

Authors:  Mandana Rafeey; Fakhrossadat Mortazavi; Nafiseh Mogaddasi; Ghergherehchi Robabeh; Shamsi Ghaffari; Alka Hasani
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

10.  Metabolic Syndrome and Serum Liver Enzymes Level at Patients with Type 2 Diabetes Mellitus.

Authors:  Miralem Music; Amela Dervisevic; Esad Pepic; Orhan Lepara; Almir Fajkic; Belma Ascic-Buturovic; Enes Tuna
Journal:  Med Arch       Date:  2015-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.